Voyager Therapeutics Inc (VYGR)
6.22
-0.47
(-7.03%)
USD |
NASDAQ |
Nov 14, 16:00
6.22
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Research and Development Expense (Quarterly): 34.45M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 34.45M |
| March 31, 2024 | 27.09M |
| December 31, 2023 | 25.76M |
| September 30, 2023 | 25.86M |
| June 30, 2023 | 21.98M |
| March 31, 2023 | 18.57M |
| December 31, 2022 | 14.55M |
| September 30, 2022 | 19.34M |
| June 30, 2022 | 12.53M |
| March 31, 2022 | 14.35M |
| December 31, 2021 | 14.02M |
| September 30, 2021 | 17.91M |
| June 30, 2021 | 19.50M |
| March 31, 2021 | 22.35M |
| December 31, 2020 | 22.00M |
| September 30, 2020 | 25.04M |
| June 30, 2020 | 29.42M |
| March 31, 2020 | 32.29M |
| December 31, 2019 | 36.55M |
| September 30, 2019 | 29.78M |
| Date | Value |
|---|---|
| June 30, 2019 | 28.58M |
| March 31, 2019 | 24.83M |
| December 31, 2018 | 16.91M |
| September 30, 2018 | 16.63M |
| June 30, 2018 | 16.51M |
| March 31, 2018 | 14.85M |
| December 31, 2017 | 13.33M |
| September 30, 2017 | 19.56M |
| June 30, 2017 | 15.30M |
| March 31, 2017 | 14.07M |
| December 31, 2016 | 12.72M |
| September 30, 2016 | 10.31M |
| June 30, 2016 | 10.48M |
| March 31, 2016 | 8.732M |
| December 31, 2015 | 9.22M |
| September 30, 2015 | 6.481M |
| June 30, 2015 | 6.455M |
| March 31, 2015 | 5.523M |
| December 31, 2014 | 2.96M |
| September 30, 2014 | 2.399M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
12.53M
Minimum
Jun 2022
36.55M
Maximum
Dec 2019
22.82M
Average
22.00M
Median
Dec 2020
Research and Development Expense (Quarterly) Benchmarks
| Rhythm Pharmaceuticals Inc | 37.93M |
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 4.672M |
| iBio Inc | 1.14M |
| Theriva Biologics Inc | 2.953M |